T 0466/09 of 08.01.2013
- European Case Law Identifier
- ECLI:EP:BA:2013:T046609.20130108
- Date of decision
- 8 January 2013
- Case number
- T 0466/09
- Online on
- 11 March 2013
- Petition for review of
- -
- Application number
- 97904470.8
- IPC class
- A61B 5/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- A method for monitoring the health of a patient by measuring and predicting the glucose level of the patient's blood sample
- Applicant name
- Nokia Corporation
- Opponent name
- Novo Nordisk A/S
Roche Diagnostics GmbH - Board
- 3.2.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Sufficiency of disclosure (yes, after amendment)
Inventive step (yes, after amendment) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of:
- claims 1 to 4 of the main request filed during the oral proceedings before the Board;
- description columns 1 to 8 filed during the oral proceedings before the Board;
- figures 1 to 4 of the patent as granted.